nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—RIPK2—ulcerative colitis	0.519	0.917	CbGaD
Vandetanib—ALB—ulcerative colitis	0.0471	0.0832	CbGaD
Vandetanib—ABCG2—Sulfasalazine—ulcerative colitis	0.0173	0.187	CbGbCtD
Vandetanib—ABCG2—Hydrocortisone—ulcerative colitis	0.0139	0.15	CbGbCtD
Vandetanib—RET—enteric nervous system—ulcerative colitis	0.0115	0.166	CbGeAlD
Vandetanib—CYP3A4—Budesonide—ulcerative colitis	0.0111	0.119	CbGbCtD
Vandetanib—ALB—Prednisone—ulcerative colitis	0.00955	0.103	CbGbCtD
Vandetanib—ABCG2—Dexamethasone—ulcerative colitis	0.00864	0.0934	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00494	0.0534	CbGbCtD
Vandetanib—CYP3A4—Nicotine—ulcerative colitis	0.00481	0.052	CbGbCtD
Vandetanib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00432	0.0466	CbGbCtD
Vandetanib—CYP3A4—Triamcinolone—ulcerative colitis	0.00374	0.0404	CbGbCtD
Vandetanib—ORM1—bile—ulcerative colitis	0.00365	0.0528	CbGeAlD
Vandetanib—CYP3A4—Betamethasone—ulcerative colitis	0.00321	0.0347	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—ulcerative colitis	0.00317	0.0342	CbGbCtD
Vandetanib—CYP3A4—Hydrocortisone—ulcerative colitis	0.003	0.0325	CbGbCtD
Vandetanib—CYP3A4—Prednisone—ulcerative colitis	0.00299	0.0323	CbGbCtD
Vandetanib—CYP3A4—Dexamethasone—ulcerative colitis	0.00187	0.0202	CbGbCtD
Vandetanib—BLK—lymphoid tissue—ulcerative colitis	0.00133	0.0193	CbGeAlD
Vandetanib—PTK6—digestive system—ulcerative colitis	0.00125	0.0181	CbGeAlD
Vandetanib—BMPR1B—epithelium—ulcerative colitis	0.00124	0.018	CbGeAlD
Vandetanib—PLK4—lymphoid tissue—ulcerative colitis	0.00104	0.0151	CbGeAlD
Vandetanib—FLT4—epithelium—ulcerative colitis	0.000981	0.0142	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—ulcerative colitis	0.000978	0.0142	CbGeAlD
Vandetanib—RIPK2—epithelium—ulcerative colitis	0.000975	0.0141	CbGeAlD
Vandetanib—LYN—lymphoid tissue—ulcerative colitis	0.000973	0.0141	CbGeAlD
Vandetanib—EPHA5—digestive system—ulcerative colitis	0.000966	0.014	CbGeAlD
Vandetanib—VEGFA—smooth muscle tissue—ulcerative colitis	0.000937	0.0136	CbGeAlD
Vandetanib—ERBB3—epithelium—ulcerative colitis	0.000934	0.0135	CbGeAlD
Vandetanib—RET—epithelium—ulcerative colitis	0.000866	0.0125	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—ulcerative colitis	0.000832	0.012	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—ulcerative colitis	0.000831	0.012	CbGeAlD
Vandetanib—TEK—epithelium—ulcerative colitis	0.000789	0.0114	CbGeAlD
Vandetanib—FYN—smooth muscle tissue—ulcerative colitis	0.000778	0.0113	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—ulcerative colitis	0.00076	0.011	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—ulcerative colitis	0.00076	0.011	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—ulcerative colitis	0.000755	0.0109	CbGeAlD
Vandetanib—ERBB3—Methyldopa—Mesalazine—ulcerative colitis	0.000754	0.315	CbGdCrCtD
Vandetanib—RIPK2—digestive system—ulcerative colitis	0.000742	0.0107	CbGeAlD
Vandetanib—FMO1—digestive system—ulcerative colitis	0.000736	0.0107	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—ulcerative colitis	0.000734	0.0106	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—ulcerative colitis	0.000719	0.0104	CbGeAlD
Vandetanib—LYN—liver—ulcerative colitis	0.000716	0.0104	CbGeAlD
Vandetanib—ERBB3—digestive system—ulcerative colitis	0.00071	0.0103	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—ulcerative colitis	0.000702	0.0102	CbGeAlD
Vandetanib—SRC—epithelium—ulcerative colitis	0.000701	0.0101	CbGeAlD
Vandetanib—SRC—smooth muscle tissue—ulcerative colitis	0.000675	0.00977	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—ulcerative colitis	0.000675	0.00977	CbGeAlD
Vandetanib—MKNK1—digestive system—ulcerative colitis	0.000667	0.00965	CbGeAlD
Vandetanib—RET—lymphoid tissue—ulcerative colitis	0.000667	0.00965	CbGeAlD
Vandetanib—FGR—lymphoid tissue—ulcerative colitis	0.000667	0.00965	CbGeAlD
Vandetanib—AXL—lymphoid tissue—ulcerative colitis	0.000664	0.00962	CbGeAlD
Vandetanib—RET—digestive system—ulcerative colitis	0.000659	0.00954	CbGeAlD
Vandetanib—FGR—digestive system—ulcerative colitis	0.000659	0.00954	CbGeAlD
Vandetanib—KDR—epithelium—ulcerative colitis	0.000645	0.00933	CbGeAlD
Vandetanib—FYN—lymphoid tissue—ulcerative colitis	0.000622	0.009	CbGeAlD
Vandetanib—KDR—smooth muscle tissue—ulcerative colitis	0.000621	0.00899	CbGeAlD
Vandetanib—FYN—digestive system—ulcerative colitis	0.000614	0.00889	CbGeAlD
Vandetanib—FLT3—liver—ulcerative colitis	0.000612	0.00886	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—ulcerative colitis	0.000608	0.00879	CbGeAlD
Vandetanib—TEK—lymphoid tissue—ulcerative colitis	0.000608	0.00879	CbGeAlD
Vandetanib—STK35—liver—ulcerative colitis	0.0006	0.00868	CbGeAlD
Vandetanib—ABL2—liver—ulcerative colitis	0.000584	0.00846	CbGeAlD
Vandetanib—EGFR—liver—ulcerative colitis	0.00057	0.00826	CbGeAlD
Vandetanib—YES1—lymphoid tissue—ulcerative colitis	0.000561	0.00812	CbGeAlD
Vandetanib—PDGFRB—epithelium—ulcerative colitis	0.000558	0.00808	CbGeAlD
Vandetanib—STK10—lymphoid tissue—ulcerative colitis	0.000556	0.00805	CbGeAlD
Vandetanib—FLT4—liver—ulcerative colitis	0.000556	0.00805	CbGeAlD
Vandetanib—YES1—digestive system—ulcerative colitis	0.000554	0.00802	CbGeAlD
Vandetanib—RIPK2—liver—ulcerative colitis	0.000553	0.008	CbGeAlD
Vandetanib—VEGFA—liver—ulcerative colitis	0.000551	0.00798	CbGeAlD
Vandetanib—STK10—digestive system—ulcerative colitis	0.000549	0.00795	CbGeAlD
Vandetanib—FMO1—liver—ulcerative colitis	0.000548	0.00794	CbGeAlD
Vandetanib—IRAK4—liver—ulcerative colitis	0.00054	0.00782	CbGeAlD
Vandetanib—SRC—lymphoid tissue—ulcerative colitis	0.00054	0.00781	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000538	0.00778	CbGeAlD
Vandetanib—SRC—digestive system—ulcerative colitis	0.000533	0.00772	CbGeAlD
Vandetanib—ERBB3—liver—ulcerative colitis	0.000529	0.00766	CbGeAlD
Vandetanib—Afatinib—ABCB1—ulcerative colitis	0.000516	0.264	CrCbGaD
Vandetanib—MKNK1—liver—ulcerative colitis	0.000497	0.00719	CbGeAlD
Vandetanib—KDR—lymphoid tissue—ulcerative colitis	0.000497	0.00719	CbGeAlD
Vandetanib—LCK—liver—ulcerative colitis	0.000491	0.0071	CbGeAlD
Vandetanib—FGR—liver—ulcerative colitis	0.000491	0.0071	CbGeAlD
Vandetanib—KDR—digestive system—ulcerative colitis	0.00049	0.0071	CbGeAlD
Vandetanib—AXL—liver—ulcerative colitis	0.000489	0.00708	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—ulcerative colitis	0.000479	0.00694	CbGeAlD
Vandetanib—FMO3—liver—ulcerative colitis	0.000474	0.00686	CbGeAlD
Vandetanib—SLK—liver—ulcerative colitis	0.000471	0.00681	CbGeAlD
Vandetanib—FYN—liver—ulcerative colitis	0.000457	0.00662	CbGeAlD
Vandetanib—MAP4K5—liver—ulcerative colitis	0.000447	0.00647	CbGeAlD
Vandetanib—TEK—liver—ulcerative colitis	0.000447	0.00647	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—ulcerative colitis	0.00043	0.00622	CbGeAlD
Vandetanib—PDGFRB—digestive system—ulcerative colitis	0.000425	0.00614	CbGeAlD
Vandetanib—YES1—liver—ulcerative colitis	0.000413	0.00598	CbGeAlD
Vandetanib—STK10—liver—ulcerative colitis	0.000409	0.00592	CbGeAlD
Vandetanib—SRC—liver—ulcerative colitis	0.000397	0.00575	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—ulcerative colitis	0.000383	0.00554	CbGeAlD
Vandetanib—Erlotinib—ALB—ulcerative colitis	0.000382	0.195	CrCbGaD
Vandetanib—ABL1—digestive system—ulcerative colitis	0.000378	0.00548	CbGeAlD
Vandetanib—MAP2K5—liver—ulcerative colitis	0.000365	0.00529	CbGeAlD
Vandetanib—KDR—liver—ulcerative colitis	0.000365	0.00529	CbGeAlD
Vandetanib—Erlotinib—ABCB1—ulcerative colitis	0.000365	0.187	CrCbGaD
Vandetanib—PDGFRB—liver—ulcerative colitis	0.000316	0.00458	CbGeAlD
Vandetanib—ORM1—liver—ulcerative colitis	0.000297	0.00429	CbGeAlD
Vandetanib—ABL1—liver—ulcerative colitis	0.000282	0.00408	CbGeAlD
Vandetanib—ALB—liver—ulcerative colitis	0.00026	0.00377	CbGeAlD
Vandetanib—Gefitinib—ALB—ulcerative colitis	0.000239	0.122	CrCbGaD
Vandetanib—Gefitinib—ABCB1—ulcerative colitis	0.000228	0.117	CrCbGaD
Vandetanib—Bosutinib—ABCB1—ulcerative colitis	0.000225	0.115	CrCbGaD
Vandetanib—VEGFA—Dexamethasone—Budesonide—ulcerative colitis	0.000216	0.09	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Budesonide—ulcerative colitis	0.000216	0.09	CbGdCrCtD
Vandetanib—ABCC1—liver—ulcerative colitis	0.000215	0.00311	CbGeAlD
Vandetanib—ABCG2—liver—ulcerative colitis	0.000178	0.00257	CbGeAlD
Vandetanib—CYP3A4—digestive system—ulcerative colitis	0.000166	0.00241	CbGeAlD
Vandetanib—CYP3A4—liver—ulcerative colitis	0.000124	0.00179	CbGeAlD
Vandetanib—VEGFA—Betamethasone—Hydrocortisone—ulcerative colitis	0.00011	0.0461	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Hydrocortisone—ulcerative colitis	0.00011	0.0461	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000104	0.0435	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—ulcerative colitis	0.000104	0.0435	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—ulcerative colitis	0.000103	0.0428	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—ulcerative colitis	0.000103	0.0428	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—ulcerative colitis	0.0001	0.0418	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—ulcerative colitis	0.0001	0.0418	CbGdCrCtD
Vandetanib—Eye disorder—Methylprednisolone—ulcerative colitis	9.88e-05	0.000845	CcSEcCtD
Vandetanib—Mental disorder—Hydrocortisone—ulcerative colitis	9.85e-05	0.000844	CcSEcCtD
Vandetanib—Cardiac disorder—Methylprednisolone—ulcerative colitis	9.81e-05	0.00084	CcSEcCtD
Vandetanib—Malnutrition—Hydrocortisone—ulcerative colitis	9.79e-05	0.000838	CcSEcCtD
Vandetanib—Bradycardia—Dexamethasone—ulcerative colitis	9.78e-05	0.000838	CcSEcCtD
Vandetanib—Bradycardia—Betamethasone—ulcerative colitis	9.78e-05	0.000838	CcSEcCtD
Vandetanib—Neutropenia—Prednisone—ulcerative colitis	9.78e-05	0.000837	CcSEcCtD
Vandetanib—Pruritus—Budesonide—ulcerative colitis	9.78e-05	0.000837	CcSEcCtD
Vandetanib—Decreased appetite—Mesalazine—ulcerative colitis	9.77e-05	0.000836	CcSEcCtD
Vandetanib—Abdominal pain—Azathioprine—ulcerative colitis	9.75e-05	0.000835	CcSEcCtD
Vandetanib—Body temperature increased—Azathioprine—ulcerative colitis	9.75e-05	0.000835	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	9.7e-05	0.000831	CcSEcCtD
Vandetanib—Fatigue—Mesalazine—ulcerative colitis	9.69e-05	0.000829	CcSEcCtD
Vandetanib—Haemoglobin—Dexamethasone—ulcerative colitis	9.66e-05	0.000827	CcSEcCtD
Vandetanib—Haemoglobin—Betamethasone—ulcerative colitis	9.66e-05	0.000827	CcSEcCtD
Vandetanib—Pain—Mesalazine—ulcerative colitis	9.61e-05	0.000823	CcSEcCtD
Vandetanib—Constipation—Mesalazine—ulcerative colitis	9.61e-05	0.000823	CcSEcCtD
Vandetanib—Haemorrhage—Dexamethasone—ulcerative colitis	9.61e-05	0.000823	CcSEcCtD
Vandetanib—Haemorrhage—Betamethasone—ulcerative colitis	9.61e-05	0.000823	CcSEcCtD
Vandetanib—Angiopathy—Methylprednisolone—ulcerative colitis	9.59e-05	0.000821	CcSEcCtD
Vandetanib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	9.52e-05	0.000815	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Prednisone—ulcerative colitis	9.51e-05	0.0397	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—ulcerative colitis	9.51e-05	0.0397	CbGdCrCtD
Vandetanib—Arrhythmia—Triamcinolone—ulcerative colitis	9.46e-05	0.00081	CcSEcCtD
Vandetanib—Weight decreased—Prednisone—ulcerative colitis	9.46e-05	0.00081	CcSEcCtD
Vandetanib—Diarrhoea—Budesonide—ulcerative colitis	9.45e-05	0.000809	CcSEcCtD
Vandetanib—Vision blurred—Prednisolone—ulcerative colitis	9.45e-05	0.000809	CcSEcCtD
Vandetanib—Arrhythmia—Methylprednisolone—ulcerative colitis	9.44e-05	0.000808	CcSEcCtD
Vandetanib—Hyperglycaemia—Prednisone—ulcerative colitis	9.43e-05	0.000807	CcSEcCtD
Vandetanib—Depression—Prednisone—ulcerative colitis	9.3e-05	0.000796	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—ulcerative colitis	9.28e-05	0.0387	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—ulcerative colitis	9.28e-05	0.0387	CbGdCrCtD
Vandetanib—Visual impairment—Dexamethasone—ulcerative colitis	9.26e-05	0.000793	CcSEcCtD
Vandetanib—Visual impairment—Betamethasone—ulcerative colitis	9.26e-05	0.000793	CcSEcCtD
Vandetanib—Mental disorder—Methylprednisolone—ulcerative colitis	9.26e-05	0.000793	CcSEcCtD
Vandetanib—Malnutrition—Methylprednisolone—ulcerative colitis	9.2e-05	0.000788	CcSEcCtD
Vandetanib—Gastrointestinal pain—Mesalazine—ulcerative colitis	9.19e-05	0.000787	CcSEcCtD
Vandetanib—Dizziness—Budesonide—ulcerative colitis	9.14e-05	0.000782	CcSEcCtD
Vandetanib—Dysgeusia—Triamcinolone—ulcerative colitis	9.03e-05	0.000773	CcSEcCtD
Vandetanib—Eye disorder—Dexamethasone—ulcerative colitis	8.98e-05	0.000769	CcSEcCtD
Vandetanib—Eye disorder—Betamethasone—ulcerative colitis	8.98e-05	0.000769	CcSEcCtD
Vandetanib—Abdominal pain—Mesalazine—ulcerative colitis	8.88e-05	0.000761	CcSEcCtD
Vandetanib—Body temperature increased—Mesalazine—ulcerative colitis	8.88e-05	0.000761	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisolone—ulcerative colitis	8.81e-05	0.000754	CcSEcCtD
Vandetanib—Vomiting—Budesonide—ulcerative colitis	8.79e-05	0.000752	CcSEcCtD
Vandetanib—Angiopathy—Dexamethasone—ulcerative colitis	8.72e-05	0.000746	CcSEcCtD
Vandetanib—Angiopathy—Betamethasone—ulcerative colitis	8.72e-05	0.000746	CcSEcCtD
Vandetanib—Rash—Budesonide—ulcerative colitis	8.71e-05	0.000746	CcSEcCtD
Vandetanib—Dermatitis—Budesonide—ulcerative colitis	8.7e-05	0.000745	CcSEcCtD
Vandetanib—Convulsion—Prednisolone—ulcerative colitis	8.69e-05	0.000744	CcSEcCtD
Vandetanib—Headache—Budesonide—ulcerative colitis	8.66e-05	0.000741	CcSEcCtD
Vandetanib—Hypertension—Prednisolone—ulcerative colitis	8.66e-05	0.000741	CcSEcCtD
Vandetanib—Loss of consciousness—Hydrocortisone—ulcerative colitis	8.61e-05	0.000737	CcSEcCtD
Vandetanib—Arrhythmia—Dexamethasone—ulcerative colitis	8.58e-05	0.000735	CcSEcCtD
Vandetanib—Arrhythmia—Betamethasone—ulcerative colitis	8.58e-05	0.000735	CcSEcCtD
Vandetanib—Bradycardia—Prednisone—ulcerative colitis	8.52e-05	0.000729	CcSEcCtD
Vandetanib—Alopecia—Dexamethasone—ulcerative colitis	8.49e-05	0.000727	CcSEcCtD
Vandetanib—Alopecia—Betamethasone—ulcerative colitis	8.49e-05	0.000727	CcSEcCtD
Vandetanib—Convulsion—Hydrocortisone—ulcerative colitis	8.48e-05	0.000726	CcSEcCtD
Vandetanib—Hypertension—Hydrocortisone—ulcerative colitis	8.45e-05	0.000724	CcSEcCtD
Vandetanib—Diarrhoea—Azathioprine—ulcerative colitis	8.44e-05	0.000723	CcSEcCtD
Vandetanib—Haemoglobin—Prednisone—ulcerative colitis	8.41e-05	0.00072	CcSEcCtD
Vandetanib—Haemorrhage—Prednisone—ulcerative colitis	8.37e-05	0.000716	CcSEcCtD
Vandetanib—Anxiety—Hydrocortisone—ulcerative colitis	8.31e-05	0.000711	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.28e-05	0.000709	CcSEcCtD
Vandetanib—Nausea—Budesonide—ulcerative colitis	8.21e-05	0.000703	CcSEcCtD
Vandetanib—Oedema—Prednisolone—ulcerative colitis	8.18e-05	0.0007	CcSEcCtD
Vandetanib—Dizziness—Azathioprine—ulcerative colitis	8.16e-05	0.000698	CcSEcCtD
Vandetanib—Loss of consciousness—Triamcinolone—ulcerative colitis	8.1e-05	0.000694	CcSEcCtD
Vandetanib—Loss of consciousness—Methylprednisolone—ulcerative colitis	8.09e-05	0.000692	CcSEcCtD
Vandetanib—Asthenia—Mesalazine—ulcerative colitis	8.06e-05	0.00069	CcSEcCtD
Vandetanib—Cough—Triamcinolone—ulcerative colitis	8.05e-05	0.000689	CcSEcCtD
Vandetanib—Oedema—Hydrocortisone—ulcerative colitis	7.99e-05	0.000684	CcSEcCtD
Vandetanib—Convulsion—Triamcinolone—ulcerative colitis	7.99e-05	0.000684	CcSEcCtD
Vandetanib—Convulsion—Methylprednisolone—ulcerative colitis	7.97e-05	0.000682	CcSEcCtD
Vandetanib—Hypertension—Triamcinolone—ulcerative colitis	7.96e-05	0.000681	CcSEcCtD
Vandetanib—Pruritus—Mesalazine—ulcerative colitis	7.95e-05	0.000681	CcSEcCtD
Vandetanib—Hypertension—Methylprednisolone—ulcerative colitis	7.94e-05	0.00068	CcSEcCtD
Vandetanib—Infection—Hydrocortisone—ulcerative colitis	7.94e-05	0.00068	CcSEcCtD
Vandetanib—Vomiting—Azathioprine—ulcerative colitis	7.84e-05	0.000672	CcSEcCtD
Vandetanib—Nervous system disorder—Hydrocortisone—ulcerative colitis	7.84e-05	0.000671	CcSEcCtD
Vandetanib—Arthralgia—Methylprednisolone—ulcerative colitis	7.83e-05	0.00067	CcSEcCtD
Vandetanib—Eye disorder—Prednisone—ulcerative colitis	7.82e-05	0.00067	CcSEcCtD
Vandetanib—Anxiety—Methylprednisolone—ulcerative colitis	7.8e-05	0.000668	CcSEcCtD
Vandetanib—Rash—Azathioprine—ulcerative colitis	7.78e-05	0.000666	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	7.78e-05	0.000666	CcSEcCtD
Vandetanib—Dermatitis—Azathioprine—ulcerative colitis	7.77e-05	0.000665	CcSEcCtD
Vandetanib—Skin disorder—Hydrocortisone—ulcerative colitis	7.76e-05	0.000664	CcSEcCtD
Vandetanib—Headache—Azathioprine—ulcerative colitis	7.73e-05	0.000662	CcSEcCtD
Vandetanib—Diarrhoea—Mesalazine—ulcerative colitis	7.69e-05	0.000658	CcSEcCtD
Vandetanib—Dry mouth—Triamcinolone—ulcerative colitis	7.68e-05	0.000657	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—ulcerative colitis	7.59e-05	0.00065	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—ulcerative colitis	7.52e-05	0.000644	CcSEcCtD
Vandetanib—Arrhythmia—Prednisone—ulcerative colitis	7.48e-05	0.00064	CcSEcCtD
Vandetanib—Infection—Triamcinolone—ulcerative colitis	7.48e-05	0.00064	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—ulcerative colitis	7.46e-05	0.000639	CcSEcCtD
Vandetanib—Dizziness—Mesalazine—ulcerative colitis	7.43e-05	0.000636	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—ulcerative colitis	7.4e-05	0.000634	CcSEcCtD
Vandetanib—Alopecia—Prednisone—ulcerative colitis	7.4e-05	0.000633	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.36e-05	0.00063	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—ulcerative colitis	7.35e-05	0.000629	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—ulcerative colitis	7.35e-05	0.000629	CcSEcCtD
Vandetanib—Paraesthesia—Prednisolone—ulcerative colitis	7.35e-05	0.000629	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—ulcerative colitis	7.33e-05	0.000628	CcSEcCtD
Vandetanib—Nausea—Azathioprine—ulcerative colitis	7.33e-05	0.000627	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—ulcerative colitis	7.29e-05	0.000624	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—ulcerative colitis	7.29e-05	0.000624	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.28e-05	0.000623	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—ulcerative colitis	7.25e-05	0.00062	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—ulcerative colitis	7.25e-05	0.00062	CcSEcCtD
Vandetanib—Insomnia—Hydrocortisone—ulcerative colitis	7.23e-05	0.000619	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—ulcerative colitis	7.22e-05	0.000618	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—ulcerative colitis	7.22e-05	0.000618	CcSEcCtD
Vandetanib—Paraesthesia—Hydrocortisone—ulcerative colitis	7.18e-05	0.000614	CcSEcCtD
Vandetanib—Vomiting—Mesalazine—ulcerative colitis	7.15e-05	0.000612	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—ulcerative colitis	7.1e-05	0.000608	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—ulcerative colitis	7.1e-05	0.000608	CcSEcCtD
Vandetanib—Rash—Mesalazine—ulcerative colitis	7.09e-05	0.000607	CcSEcCtD
Vandetanib—Dermatitis—Mesalazine—ulcerative colitis	7.08e-05	0.000606	CcSEcCtD
Vandetanib—Headache—Mesalazine—ulcerative colitis	7.04e-05	0.000603	CcSEcCtD
Vandetanib—Dyspepsia—Hydrocortisone—ulcerative colitis	7.03e-05	0.000602	CcSEcCtD
Vandetanib—Pain—Prednisolone—ulcerative colitis	7e-05	0.000599	CcSEcCtD
Vandetanib—Decreased appetite—Hydrocortisone—ulcerative colitis	6.95e-05	0.000595	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	6.9e-05	0.000591	CcSEcCtD
Vandetanib—Fatigue—Hydrocortisone—ulcerative colitis	6.89e-05	0.00059	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—ulcerative colitis	6.87e-05	0.000588	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	6.86e-05	0.000587	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	6.84e-05	0.000586	CcSEcCtD
Vandetanib—Pain—Hydrocortisone—ulcerative colitis	6.83e-05	0.000585	CcSEcCtD
Vandetanib—Oedema—Betamethasone—ulcerative colitis	6.83e-05	0.000584	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—ulcerative colitis	6.83e-05	0.000584	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—ulcerative colitis	6.81e-05	0.000583	CcSEcCtD
Vandetanib—Insomnia—Methylprednisolone—ulcerative colitis	6.79e-05	0.000581	CcSEcCtD
Vandetanib—Infection—Betamethasone—ulcerative colitis	6.78e-05	0.000581	CcSEcCtD
Vandetanib—Infection—Dexamethasone—ulcerative colitis	6.78e-05	0.000581	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—ulcerative colitis	6.76e-05	0.000578	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—ulcerative colitis	6.74e-05	0.000577	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—ulcerative colitis	6.71e-05	0.000574	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—ulcerative colitis	6.7e-05	0.000573	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—ulcerative colitis	6.7e-05	0.000573	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—ulcerative colitis	6.68e-05	0.000572	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—ulcerative colitis	6.68e-05	0.000572	CcSEcCtD
Vandetanib—Nausea—Mesalazine—ulcerative colitis	6.68e-05	0.000571	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—ulcerative colitis	6.62e-05	0.000567	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—ulcerative colitis	6.61e-05	0.000566	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.53e-05	0.000559	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—ulcerative colitis	6.49e-05	0.000555	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—ulcerative colitis	6.47e-05	0.000554	CcSEcCtD
Vandetanib—Pain—Triamcinolone—ulcerative colitis	6.43e-05	0.000551	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—ulcerative colitis	6.4e-05	0.000548	CcSEcCtD
Vandetanib—Abdominal pain—Hydrocortisone—ulcerative colitis	6.32e-05	0.000541	CcSEcCtD
Vandetanib—Body temperature increased—Hydrocortisone—ulcerative colitis	6.32e-05	0.000541	CcSEcCtD
Vandetanib—Convulsion—Prednisone—ulcerative colitis	6.31e-05	0.00054	CcSEcCtD
Vandetanib—Hypertension—Prednisone—ulcerative colitis	6.29e-05	0.000538	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.22e-05	0.000533	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.22e-05	0.000533	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—ulcerative colitis	6.2e-05	0.000531	CcSEcCtD
Vandetanib—Anxiety—Prednisone—ulcerative colitis	6.18e-05	0.000529	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—ulcerative colitis	6.18e-05	0.000529	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—ulcerative colitis	6.18e-05	0.000529	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.16e-05	0.000527	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.14e-05	0.000526	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—ulcerative colitis	6.13e-05	0.000525	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—ulcerative colitis	6.13e-05	0.000525	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—ulcerative colitis	6.01e-05	0.000514	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—ulcerative colitis	6.01e-05	0.000514	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—ulcerative colitis	5.95e-05	0.000509	CcSEcCtD
Vandetanib—Oedema—Prednisone—ulcerative colitis	5.95e-05	0.000509	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—ulcerative colitis	5.94e-05	0.000508	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—ulcerative colitis	5.94e-05	0.000508	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—ulcerative colitis	5.94e-05	0.000508	CcSEcCtD
Vandetanib—Infection—Prednisone—ulcerative colitis	5.91e-05	0.000506	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	5.89e-05	0.000505	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	5.89e-05	0.000505	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—ulcerative colitis	5.89e-05	0.000504	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—ulcerative colitis	5.89e-05	0.000504	CcSEcCtD
Vandetanib—Pain—Betamethasone—ulcerative colitis	5.84e-05	0.0005	CcSEcCtD
Vandetanib—Pain—Dexamethasone—ulcerative colitis	5.84e-05	0.0005	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—ulcerative colitis	5.83e-05	0.000499	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—ulcerative colitis	5.78e-05	0.000494	CcSEcCtD
Vandetanib—Asthenia—Hydrocortisone—ulcerative colitis	5.73e-05	0.000491	CcSEcCtD
Vandetanib—Pruritus—Hydrocortisone—ulcerative colitis	5.65e-05	0.000484	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.58e-05	0.000478	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.58e-05	0.000478	CcSEcCtD
Vandetanib—Diarrhoea—Hydrocortisone—ulcerative colitis	5.47e-05	0.000468	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.42e-05	0.000464	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—ulcerative colitis	5.41e-05	0.000463	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—ulcerative colitis	5.4e-05	0.000462	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—ulcerative colitis	5.4e-05	0.000462	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—ulcerative colitis	5.4e-05	0.000462	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—ulcerative colitis	5.4e-05	0.000462	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—ulcerative colitis	5.4e-05	0.000462	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—ulcerative colitis	5.39e-05	0.000461	CcSEcCtD
Vandetanib—Insomnia—Prednisone—ulcerative colitis	5.38e-05	0.00046	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—ulcerative colitis	5.34e-05	0.000457	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—ulcerative colitis	5.32e-05	0.000456	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—ulcerative colitis	5.31e-05	0.000455	CcSEcCtD
Vandetanib—Dizziness—Hydrocortisone—ulcerative colitis	5.28e-05	0.000452	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—ulcerative colitis	5.23e-05	0.000448	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—ulcerative colitis	5.17e-05	0.000442	CcSEcCtD
Vandetanib—Rash—Prednisolone—ulcerative colitis	5.16e-05	0.000442	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—ulcerative colitis	5.15e-05	0.000441	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—ulcerative colitis	5.14e-05	0.00044	CcSEcCtD
Vandetanib—Fatigue—Prednisone—ulcerative colitis	5.13e-05	0.000439	CcSEcCtD
Vandetanib—Headache—Prednisolone—ulcerative colitis	5.13e-05	0.000439	CcSEcCtD
Vandetanib—Constipation—Prednisone—ulcerative colitis	5.08e-05	0.000435	CcSEcCtD
Vandetanib—Vomiting—Hydrocortisone—ulcerative colitis	5.08e-05	0.000435	CcSEcCtD
Vandetanib—Rash—Hydrocortisone—ulcerative colitis	5.04e-05	0.000431	CcSEcCtD
Vandetanib—Dermatitis—Hydrocortisone—ulcerative colitis	5.03e-05	0.000431	CcSEcCtD
Vandetanib—Headache—Hydrocortisone—ulcerative colitis	5.01e-05	0.000429	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—ulcerative colitis	4.98e-05	0.000426	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—ulcerative colitis	4.96e-05	0.000425	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—ulcerative colitis	4.9e-05	0.000419	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—ulcerative colitis	4.9e-05	0.000419	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—ulcerative colitis	4.86e-05	0.000416	CcSEcCtD
Vandetanib—Nausea—Prednisolone—ulcerative colitis	4.86e-05	0.000416	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—ulcerative colitis	4.83e-05	0.000414	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—ulcerative colitis	4.83e-05	0.000414	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—ulcerative colitis	4.78e-05	0.00041	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—ulcerative colitis	4.77e-05	0.000409	CcSEcCtD
Vandetanib—Nausea—Hydrocortisone—ulcerative colitis	4.75e-05	0.000406	CcSEcCtD
Vandetanib—Rash—Triamcinolone—ulcerative colitis	4.74e-05	0.000406	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—ulcerative colitis	4.74e-05	0.000406	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—ulcerative colitis	4.73e-05	0.000405	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—ulcerative colitis	4.73e-05	0.000405	CcSEcCtD
Vandetanib—Headache—Triamcinolone—ulcerative colitis	4.71e-05	0.000404	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—ulcerative colitis	4.7e-05	0.000403	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—ulcerative colitis	4.7e-05	0.000402	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—ulcerative colitis	4.7e-05	0.000402	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—ulcerative colitis	4.67e-05	0.0004	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—ulcerative colitis	4.67e-05	0.0004	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—ulcerative colitis	4.51e-05	0.000387	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—ulcerative colitis	4.51e-05	0.000387	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—ulcerative colitis	4.47e-05	0.000383	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—ulcerative colitis	4.46e-05	0.000382	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—ulcerative colitis	4.34e-05	0.000372	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—ulcerative colitis	4.34e-05	0.000372	CcSEcCtD
Vandetanib—Rash—Betamethasone—ulcerative colitis	4.3e-05	0.000369	CcSEcCtD
Vandetanib—Rash—Dexamethasone—ulcerative colitis	4.3e-05	0.000369	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—ulcerative colitis	4.3e-05	0.000368	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—ulcerative colitis	4.3e-05	0.000368	CcSEcCtD
Vandetanib—Headache—Dexamethasone—ulcerative colitis	4.28e-05	0.000366	CcSEcCtD
Vandetanib—Headache—Betamethasone—ulcerative colitis	4.28e-05	0.000366	CcSEcCtD
Vandetanib—Asthenia—Prednisone—ulcerative colitis	4.27e-05	0.000365	CcSEcCtD
Vandetanib—Pruritus—Prednisone—ulcerative colitis	4.21e-05	0.00036	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—ulcerative colitis	4.07e-05	0.000348	CcSEcCtD
Vandetanib—Nausea—Betamethasone—ulcerative colitis	4.06e-05	0.000347	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—ulcerative colitis	4.06e-05	0.000347	CcSEcCtD
Vandetanib—Dizziness—Prednisone—ulcerative colitis	3.93e-05	0.000337	CcSEcCtD
Vandetanib—Vomiting—Prednisone—ulcerative colitis	3.78e-05	0.000324	CcSEcCtD
Vandetanib—Rash—Prednisone—ulcerative colitis	3.75e-05	0.000321	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—ulcerative colitis	3.75e-05	0.000321	CcSEcCtD
Vandetanib—Headache—Prednisone—ulcerative colitis	3.72e-05	0.000319	CcSEcCtD
Vandetanib—Nausea—Prednisone—ulcerative colitis	3.53e-05	0.000302	CcSEcCtD
Vandetanib—PDGFRB—Disease—JAK2—ulcerative colitis	3.48e-06	2.3e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TGFB1—ulcerative colitis	3.48e-06	2.3e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—ICAM1—ulcerative colitis	3.46e-06	2.29e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CXCL8—ulcerative colitis	3.45e-06	2.29e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CDH1—ulcerative colitis	3.45e-06	2.28e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—JAK2—ulcerative colitis	3.45e-06	2.28e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TP53—ulcerative colitis	3.45e-06	2.28e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD4—ulcerative colitis	3.45e-06	2.28e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—JAK2—ulcerative colitis	3.44e-06	2.27e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS1—ulcerative colitis	3.44e-06	2.27e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP9—ulcerative colitis	3.42e-06	2.26e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NFKB1—ulcerative colitis	3.38e-06	2.24e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CXCL8—ulcerative colitis	3.37e-06	2.23e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—JAK2—ulcerative colitis	3.36e-06	2.22e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CXCL8—ulcerative colitis	3.33e-06	2.2e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—IL6—ulcerative colitis	3.32e-06	2.2e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—JAK2—ulcerative colitis	3.32e-06	2.19e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—ulcerative colitis	3.31e-06	2.19e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—ulcerative colitis	3.3e-06	2.19e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—ulcerative colitis	3.3e-06	2.18e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL2—ulcerative colitis	3.3e-06	2.18e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL2—ulcerative colitis	3.29e-06	2.18e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL6—ulcerative colitis	3.28e-06	2.17e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTGS2—ulcerative colitis	3.28e-06	2.17e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ADRB2—ulcerative colitis	3.27e-06	2.17e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ADCY5—ulcerative colitis	3.26e-06	2.16e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—IL6—ulcerative colitis	3.25e-06	2.15e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—IL6—ulcerative colitis	3.24e-06	2.14e-05	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—TP53—ulcerative colitis	3.23e-06	2.14e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—ulcerative colitis	3.23e-06	2.14e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL2—ulcerative colitis	3.22e-06	2.13e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—ulcerative colitis	3.22e-06	2.13e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL2—ulcerative colitis	3.22e-06	2.13e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—RELA—ulcerative colitis	3.21e-06	2.12e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL2—ulcerative colitis	3.21e-06	2.12e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—JAK2—ulcerative colitis	3.2e-06	2.12e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—IL6—ulcerative colitis	3.2e-06	2.12e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—ulcerative colitis	3.18e-06	2.11e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—ulcerative colitis	3.18e-06	2.11e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL2—ulcerative colitis	3.18e-06	2.11e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—ulcerative colitis	3.17e-06	2.1e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PTGS2—ulcerative colitis	3.16e-06	2.09e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL6—ulcerative colitis	3.16e-06	2.09e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL6—ulcerative colitis	3.16e-06	2.09e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL6—ulcerative colitis	3.15e-06	2.08e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—JAK2—ulcerative colitis	3.14e-06	2.08e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	3.14e-06	2.08e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CXCL8—ulcerative colitis	3.14e-06	2.08e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—IL6—ulcerative colitis	3.13e-06	2.07e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—ulcerative colitis	3.13e-06	2.07e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RELA—ulcerative colitis	3.1e-06	2.05e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CALM3—ulcerative colitis	3.09e-06	2.05e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NFKB1—ulcerative colitis	3.09e-06	2.05e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—ulcerative colitis	3.08e-06	2.04e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PPARG—ulcerative colitis	3.08e-06	2.04e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NFKB1—ulcerative colitis	3.08e-06	2.04e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—JAK2—ulcerative colitis	3.08e-06	2.04e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CDH1—ulcerative colitis	3.06e-06	2.02e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—ulcerative colitis	3.05e-06	2.01e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—RELA—ulcerative colitis	3.04e-06	2.01e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—STAT3—ulcerative colitis	3.04e-06	2.01e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—JAK2—ulcerative colitis	3.03e-06	2e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CXCL8—ulcerative colitis	3.03e-06	2e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—NFKB1—ulcerative colitis	3.02e-06	2e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NFKB1—ulcerative colitis	3.01e-06	1.99e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—ulcerative colitis	3.01e-06	1.99e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—ulcerative colitis	3.01e-06	1.99e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NFKB1—ulcerative colitis	3e-06	1.99e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—ulcerative colitis	3e-06	1.98e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NFKB1—ulcerative colitis	2.98e-06	1.97e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—ulcerative colitis	2.98e-06	1.97e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—ulcerative colitis	2.97e-06	1.97e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—NFKB1—ulcerative colitis	2.97e-06	1.96e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.96e-06	1.96e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—RELA—ulcerative colitis	2.93e-06	1.94e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CXCL8—ulcerative colitis	2.92e-06	1.93e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—ulcerative colitis	2.92e-06	1.93e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—JAK2—ulcerative colitis	2.9e-06	1.92e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—ulcerative colitis	2.9e-06	1.92e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—ulcerative colitis	2.89e-06	1.91e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—ulcerative colitis	2.89e-06	1.91e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—ulcerative colitis	2.87e-06	1.9e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TP53—ulcerative colitis	2.86e-06	1.89e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—ulcerative colitis	2.82e-06	1.86e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—JAK2—ulcerative colitis	2.8e-06	1.85e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—ulcerative colitis	2.79e-06	1.85e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ADCY5—ulcerative colitis	2.78e-06	1.84e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	2.78e-06	1.84e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—ulcerative colitis	2.77e-06	1.83e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—STAT3—ulcerative colitis	2.77e-06	1.83e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—ulcerative colitis	2.77e-06	1.83e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—ulcerative colitis	2.75e-06	1.82e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—ulcerative colitis	2.75e-06	1.82e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—ulcerative colitis	2.74e-06	1.81e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—ulcerative colitis	2.74e-06	1.81e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—ulcerative colitis	2.73e-06	1.81e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PPARG—ulcerative colitis	2.71e-06	1.79e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—STAT3—ulcerative colitis	2.71e-06	1.79e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NFKB1—ulcerative colitis	2.71e-06	1.79e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—STAT3—ulcerative colitis	2.71e-06	1.79e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—STAT3—ulcerative colitis	2.7e-06	1.79e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—JAK2—ulcerative colitis	2.68e-06	1.77e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—STAT3—ulcerative colitis	2.68e-06	1.77e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—ulcerative colitis	2.67e-06	1.77e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—ulcerative colitis	2.67e-06	1.77e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—STAT3—ulcerative colitis	2.67e-06	1.77e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—ulcerative colitis	2.67e-06	1.76e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—ulcerative colitis	2.65e-06	1.75e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—ulcerative colitis	2.65e-06	1.75e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—ulcerative colitis	2.64e-06	1.75e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—ulcerative colitis	2.64e-06	1.75e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—ulcerative colitis	2.63e-06	1.74e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—ulcerative colitis	2.63e-06	1.74e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NFKB1—ulcerative colitis	2.62e-06	1.73e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—RELA—ulcerative colitis	2.6e-06	1.72e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	2.58e-06	1.7e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NFKB1—ulcerative colitis	2.57e-06	1.7e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—STAT3—ulcerative colitis	2.56e-06	1.69e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—ulcerative colitis	2.54e-06	1.68e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—ulcerative colitis	2.54e-06	1.68e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—ulcerative colitis	2.51e-06	1.66e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—ulcerative colitis	2.48e-06	1.64e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—JAK2—ulcerative colitis	2.47e-06	1.64e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—NFKB1—ulcerative colitis	2.47e-06	1.64e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—STAT3—ulcerative colitis	2.46e-06	1.63e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—ulcerative colitis	2.44e-06	1.61e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	2.44e-06	1.61e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—STAT3—ulcerative colitis	2.43e-06	1.61e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—ulcerative colitis	2.43e-06	1.6e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ABCB1—ulcerative colitis	2.41e-06	1.59e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—JAK2—ulcerative colitis	2.39e-06	1.58e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—ulcerative colitis	2.37e-06	1.57e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	2.36e-06	1.56e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—ulcerative colitis	2.36e-06	1.56e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—JAK2—ulcerative colitis	2.35e-06	1.56e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—STAT3—ulcerative colitis	2.35e-06	1.56e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—ulcerative colitis	2.35e-06	1.55e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—ulcerative colitis	2.35e-06	1.55e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—ulcerative colitis	2.35e-06	1.55e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—ulcerative colitis	2.34e-06	1.55e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—ulcerative colitis	2.33e-06	1.54e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TP53—ulcerative colitis	2.32e-06	1.53e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RELA—ulcerative colitis	2.31e-06	1.53e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—STAT3—ulcerative colitis	2.31e-06	1.53e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—ulcerative colitis	2.28e-06	1.51e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RELA—ulcerative colitis	2.28e-06	1.51e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—STAT3—ulcerative colitis	2.26e-06	1.49e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—ulcerative colitis	2.26e-06	1.49e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ADCY5—ulcerative colitis	2.24e-06	1.48e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	2.23e-06	1.47e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—STAT3—ulcerative colitis	2.22e-06	1.47e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—NFKB1—ulcerative colitis	2.19e-06	1.45e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	2.18e-06	1.44e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—ulcerative colitis	2.18e-06	1.44e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—ulcerative colitis	2.15e-06	1.42e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—ulcerative colitis	2.13e-06	1.41e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—STAT3—ulcerative colitis	2.13e-06	1.41e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	2.13e-06	1.41e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—ulcerative colitis	2.12e-06	1.4e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	2.12e-06	1.4e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—ulcerative colitis	2.09e-06	1.39e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—ulcerative colitis	2.08e-06	1.38e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TP53—ulcerative colitis	2.07e-06	1.37e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—STAT3—ulcerative colitis	2.05e-06	1.36e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—ulcerative colitis	2.05e-06	1.36e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TP53—ulcerative colitis	2.04e-06	1.35e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—JAK2—ulcerative colitis	2.03e-06	1.34e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	2.01e-06	1.33e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	1.99e-06	1.32e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—ulcerative colitis	1.97e-06	1.31e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—ulcerative colitis	1.97e-06	1.3e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—STAT3—ulcerative colitis	1.97e-06	1.3e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RELA—ulcerative colitis	1.97e-06	1.3e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—JAK2—ulcerative colitis	1.96e-06	1.29e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	1.95e-06	1.29e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—ulcerative colitis	1.94e-06	1.28e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	1.94e-06	1.28e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—ulcerative colitis	1.93e-06	1.28e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TP53—ulcerative colitis	1.93e-06	1.28e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NFKB1—ulcerative colitis	1.92e-06	1.27e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—ulcerative colitis	1.9e-06	1.26e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RELA—ulcerative colitis	1.9e-06	1.25e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—ulcerative colitis	1.89e-06	1.25e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—ulcerative colitis	1.89e-06	1.25e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—ulcerative colitis	1.89e-06	1.25e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—ulcerative colitis	1.87e-06	1.24e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—ulcerative colitis	1.86e-06	1.23e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TP53—ulcerative colitis	1.86e-06	1.23e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.86e-06	1.23e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	1.85e-06	1.23e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—STAT3—ulcerative colitis	1.82e-06	1.2e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TP53—ulcerative colitis	1.79e-06	1.19e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	1.79e-06	1.18e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	1.79e-06	1.18e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—ulcerative colitis	1.79e-06	1.18e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—ulcerative colitis	1.77e-06	1.17e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—ulcerative colitis	1.76e-06	1.17e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—STAT3—ulcerative colitis	1.75e-06	1.16e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—JAK2—ulcerative colitis	1.73e-06	1.15e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—STAT3—ulcerative colitis	1.73e-06	1.14e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—ulcerative colitis	1.72e-06	1.14e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—ulcerative colitis	1.71e-06	1.13e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—ulcerative colitis	1.7e-06	1.12e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—ulcerative colitis	1.68e-06	1.11e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RELA—ulcerative colitis	1.68e-06	1.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—ulcerative colitis	1.68e-06	1.11e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARG—ulcerative colitis	1.67e-06	1.11e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.67e-06	1.1e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	1.66e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	1.66e-06	1.1e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—ulcerative colitis	1.64e-06	1.09e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	1.62e-06	1.07e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—ulcerative colitis	1.62e-06	1.07e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—ulcerative colitis	1.61e-06	1.07e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—ulcerative colitis	1.6e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	1.6e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—ulcerative colitis	1.58e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—ulcerative colitis	1.58e-06	1.04e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—ulcerative colitis	1.55e-06	1.03e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—ulcerative colitis	1.51e-06	1e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—STAT3—ulcerative colitis	1.49e-06	9.86e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—ulcerative colitis	1.49e-06	9.84e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—STAT3—ulcerative colitis	1.44e-06	9.5e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—ulcerative colitis	1.43e-06	9.48e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—ulcerative colitis	1.43e-06	9.46e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NFKB1—ulcerative colitis	1.42e-06	9.36e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	1.38e-06	9.14e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—ulcerative colitis	1.37e-06	9.09e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	1.37e-06	9.04e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TP53—ulcerative colitis	1.34e-06	8.85e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	1.33e-06	8.81e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—ulcerative colitis	1.32e-06	8.71e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TP53—ulcerative colitis	1.32e-06	8.71e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.3e-06	8.59e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—STAT3—ulcerative colitis	1.27e-06	8.41e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—ulcerative colitis	1.27e-06	8.39e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	1.25e-06	8.27e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—ulcerative colitis	1.22e-06	8.1e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.21e-06	8.02e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—ulcerative colitis	1.21e-06	7.97e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—ulcerative colitis	1.18e-06	7.8e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TP53—ulcerative colitis	1.14e-06	7.53e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TP53—ulcerative colitis	1.1e-06	7.25e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—ulcerative colitis	1.04e-06	6.89e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—ulcerative colitis	1e-06	6.64e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TP53—ulcerative colitis	9.71e-07	6.42e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.04e-07	5.98e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—ulcerative colitis	8.88e-07	5.88e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—ulcerative colitis	8.13e-07	5.38e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.11e-07	4.7e-06	CbGpPWpGaD
